Keyphrases
Minimal Residual Disease
100%
Acute Lymphoblastic Leukemia
100%
Hypodiploidy
100%
Transplantation
50%
Survival Rate
33%
Event-free Survival
33%
5-year Survival
33%
Allogeneic Transplantation
33%
Remission Induction
33%
Clinical Trials
16%
Clinical Characteristics
16%
Overall Survival Rate
16%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
16%
Prognostic Factors
16%
Therapeutic Response
16%
Improved Outcomes
16%
Favorable Prognosis
16%
Chemotherapy-only
16%
Newly Diagnosed
16%
Poisson Model
16%
Assessment Treatment
16%
Disease Status
16%
Disease-free Survival
16%
Cooperative Study
16%
Chemotherapy Alone
16%
Prognostic Utility
16%
Stratified Treatment
16%
Covariables
16%
Waiting Time
16%
Biologic Characteristics
16%
P-16
16%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Minimal Residual Disease
100%
Survival Rate
66%
Event Free Survival
33%
Allograft
33%
Spontaneous Remission
33%
Chemotherapy
33%
Clinical Trial
16%
Treatment Response
16%
Overall Survival
16%
Prognostic Factor
16%
Retrospective Study
16%
Cell Transplantation
16%
Disease Free Survival
16%
Disease Assessment
16%
Hematopoietic Cell
16%
Biochemistry, Genetics and Molecular Biology
Survival Rate
100%
Event Free Survival
50%
Clinical Trial
25%
Overall Survival
25%
Cell Transplantation
25%
Retrospective Study
25%
Disease Free Survival
25%
Hematopoietic Cell
25%